Liminal BioSciences to Present at BIO CEO & Investor Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Liminal BioSciences Inc. (Nasdaq: LMNL) announced that CEO Bruce Pritchard will present a company overview at the BIO CEO & Investor Conference on February 7, 2023, at 10:30 am (ET) at the New York Marriott Marquis. The company is a development-stage biopharmaceutical firm focused on creating novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases. They are currently advancing GPR84 antagonists and OXER1 antagonists while exploring other opportunities. Liminal operates in Canada and the UK, and is available for meetings through the BIO One-on-One Partnering system.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The Company will be available for meetings with conference attendees. Those interested in scheduling a meeting may do so through the BIO One-on-One Partnering system: https://www.bio.org/events/bio-ceo-investor-digital-conference/partnering,or by emailing our corporate contact using the information provided at the end of this press release.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words "anticipate," "expect," "suggest," "plan," "believe," "intend," "estimate," "target," "project," "should," "could," "would," "may," "will," "forecast" and other similar expressions are intended to identify forward-looking statements. Forward–looking statements include, among other things, our ability to regain compliance with the Nasdaq listing rules and; the potential development of
View original content to download multimedia:https://www.prnewswire.com/news-releases/liminal-biosciences-to-present-at-bio-ceo--investor-conference-301726320.html
SOURCE
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.